Cereno Scientific AB (publ) announced Etienne Adriansen to the newly created position of Chief Business Officer, as of March 1, 2023. The appointment adds commercial expertise and capacity to Cereno's Executive Management Team as business development is an active and important component of the company's growth strategy. As Chief Business Officer, Etienne will be responsible for establishing and leading Cereno's business development, leveraging his expertise in business strategy, portfolio management, licensing, transactions and establishing strategic collaborations.

Etienne has an M.Sc. in Business Administration & Commercial Law and holds over 20 years of collected experience in various commercial roles, business development and R&D from companies such as Lundbeck, Nycomed and LEO Pharma. Etienne joins Cereno from Cessatech where he held the role of Senior Director Business Development.